These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6942668)
41. Thrombocytopenia in an RA patient after taking gold and then penicillamine. Gow PJ J Rheumatol; 1980; 7(3):430. PubMed ID: 7401082 [No Abstract] [Full Text] [Related]
43. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens. Moens HJ; Ament BJ; Feltkamp BW; van der Korst JK J Rheumatol; 1987 Dec; 14(6):1115-9. PubMed ID: 3437418 [TBL] [Abstract][Full Text] [Related]
44. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy. Billingsley LM; Stevens MB Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401 [TBL] [Abstract][Full Text] [Related]
45. Containing costs in chronic disease: monitoring strategies in the gold therapy of rheumatoid arthritis. Liang MH; Fries JF J Rheumatol; 1978; 5(3):241-4. PubMed ID: 748547 [No Abstract] [Full Text] [Related]
46. HLA class-I and class-II antigen association in rheumatoid arthritis at Varanasi, India. Agrawal V; Gupta RM; Usha ; Sharma SV Indian J Pathol Microbiol; 1996 Jan; 39(1):19-25. PubMed ID: 8755127 [TBL] [Abstract][Full Text] [Related]
47. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate. Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585 [TBL] [Abstract][Full Text] [Related]
49. Serum IgA levels and ANA behaviour in rheumatoid patients with and without toxicity to remission-inducing drugs. Ferraccioli GF; Nervetti A; Mercadanti M; Cavalieri F Clin Exp Rheumatol; 1986; 4(3):217-20. PubMed ID: 2945684 [TBL] [Abstract][Full Text] [Related]
50. [Pulmonary toxicity of gold salts]. Fernández Casares M; Casas HA; Leczycki H Medicina (B Aires); 1991; 51(1):59-61. PubMed ID: 1669957 [TBL] [Abstract][Full Text] [Related]
51. HLA antigens and drug toxicity in rheumatoid arthritis. Ford PM J Rheumatol; 1984 Jun; 11(3):259-61. PubMed ID: 6610749 [No Abstract] [Full Text] [Related]
52. D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3. Emery P; Panayi GS; Huston G; Welsh KI; Mitchell SC; Shah RR; Idle JR; Smith RL; Waring RH J Rheumatol; 1984 Oct; 11(5):626-32. PubMed ID: 6334741 [TBL] [Abstract][Full Text] [Related]
53. Observations on the clinical and therapeutic aspects of gold induced thrombocytopenia. Barton JJ; Burke JP; Casey EB; McCann SR Ir Med J; 1985 Jun; 78(6):167-9. PubMed ID: 3924856 [No Abstract] [Full Text] [Related]
54. An immunogenetic study of older age onset rheumatoid arthritis. Terkeltaub R; Décary F; Esdaile J J Rheumatol; 1984 Apr; 11(2):147-9. PubMed ID: 6610048 [TBL] [Abstract][Full Text] [Related]
55. Does hypothyroidism predispose to gold-induced thrombocytopenia? Hunter JA; Capell HA Scott Med J; 1982 Jul; 27(3):247-9. PubMed ID: 6810460 [TBL] [Abstract][Full Text] [Related]
56. Renal tubular dysfunction as a complication of gold therapy in patients with rheumatoid arthritis. Iesato K; Mori Y; Ueda S; Wakashin Y; Wakashin M; Matsui N; Inoue S; Okuda K Clin Nephrol; 1982 Jan; 17(1):46-52. PubMed ID: 7035044 [TBL] [Abstract][Full Text] [Related]
57. Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. Schiff B; Mizrachi Y; Orgad S; Yaron M; Gazit E Ann Rheum Dis; 1982 Aug; 41(4):403-4. PubMed ID: 6981387 [TBL] [Abstract][Full Text] [Related]
58. [Panmyelopathy following gold therapy of primary chronic polyarthritis. Pathogenetic aspects of gold damage]. Ganzoni A; Böhni P Schweiz Med Wochenschr; 1965 Oct; 95(42):1390-4. PubMed ID: 5865085 [No Abstract] [Full Text] [Related]